TENX (Tenax Therapeutics) Cyclically Adjusted Book per Share: $6,631.77 (As of Mar. 2026)


TENX Tenax Therapeutics Inc TENX
22 GF Score
Price $15.49
! 2 Warning Signs
View Full Analysis

What is Tenax Therapeutics Cyclically Adjusted Book per Share?

Tenax Therapeutics TENX +16.42% 22 Cyclically Adjusted Book per Share is $6,631.77 as of Mar. 2026. GuruFocus rates TENX with a GF Score™ of 22/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Tenax Therapeutics's adjusted book value per share for the three months ended in Mar. 2026 was $4.725. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $6,631.77 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Tenax Therapeutics's average Cyclically Adjusted Book Growth Rate was -56.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -32.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -20.80% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -16.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Tenax Therapeutics was -6.50% per year. The lowest was -32.60% per year. And the median was -15.20% per year.

As of today (2026-07-03), Tenax Therapeutics's current stock price is $15.49. Tenax Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $6,631.77. Tenax Therapeutics's Cyclically Adjusted PB Ratio of today is 0.00.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Tenax Therapeutics was 1.20. The lowest was 0.01. And the median was 0.04.


Tenax Therapeutics  (NAS:TENX) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Tenax Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=15.49/6631.77
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Tenax Therapeutics was 1.20. The lowest was 0.01. And the median was 0.04.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Tenax Therapeutics Cyclically Adjusted Book per Share Related Terms


Tenax Therapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Tenax Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tenax Therapeutics Cyclically Adjusted Book per Share Chart

Tenax Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28,976.62 27,344.04 25,366.29 17,410.98 8,390.41

Tenax Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15,064.88 12,795.18 10,592.09 8,390.41 6,631.77

TENX vs RCKT, AVIR, VNDA: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Tenax Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tenax Therapeutics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tenax Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Tenax Therapeutics's Cyclically Adjusted PB Ratio falls into.


TENX
22GF Score
Tenax Therapeutics Inc TENX
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tenax Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Tenax Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=4.725/330.2130*330.2130
=4.725

Current CPI (Mar. 2026) = 330.2130.

Tenax Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201606 50,894.000 241.018 69,728.653
201609 46,693.000 241.428 63,864.322
201612 17,141.000 241.432 23,444.204
201703 14,113.000 243.801 19,115.164
201706 11,266.000 244.955 15,187.196
201709 10,164.000 246.819 13,598.163
201712 8,882.000 246.524 11,897.227
201803 8,001.000 249.554 10,587.024
201806 6,233.000 251.989 8,167.887
201809 4,938.000 252.439 6,459.350
201812 5,886.000 251.233 7,736.379
201903 2,585.000 254.202 3,357.962
201906 2,155.000 256.143 2,778.171
201909 1,634.250 256.759 2,101.779
201912 943.000 256.974 1,211.760
202003 683.800 258.115 874.803
202006 504.833 257.797 646.642
202009 925.500 260.280 1,174.167
202012 578.250 260.474 733.070
202103 344.000 264.877 428.853
202106 91.938 271.696 111.739
202109 452.438 274.310 544.643
202112 265.313 278.802 314.237
202203 100.375 287.504 115.286
202206 424.000 296.311 472.511
202209 208.105 296.808 231.527
202212 51.483 296.797 57.279
202303 52.493 301.836 57.428
202306 44.369 305.109 48.020
202309 37.876 307.789 40.635
202312 27.174 306.746 29.253
202403 6.348 312.332 6.711
202406 4.533 314.175 4.764
202409 28.520 315.301 29.869
202412 26.891 315.605 28.136
202503 27.529 319.799 28.425
202506 24.911 322.561 25.502
202509 16.288 324.800 16.559
202512 10.422 324.054 10.620
202603 4.725 330.213 4.725

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $6,631.77 mean?
Tenax Therapeutics (TENX) has a Cyclically Adjusted Book per Share of $6,631.77 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Tenax Therapeutics and its competitors.
Is Tenax Therapeutics' Cyclically Adjusted Book per Share too high?
Tenax Therapeutics' current Cyclically Adjusted Book per Share is $6,631.77. Overall, Tenax Therapeutics has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Tenax Therapeutics' Cyclically Adjusted Book per Share compare to RCKT and AVIR?
Tenax Therapeutics' Cyclically Adjusted Book per Share of $6,631.77 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Tenax Therapeutics and its competitors. Tenax Therapeutics's current Cyclically Adjusted Book per Share is $6,631.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tenax Therapeutics stock overvalued right now?
Tenax Therapeutics (TENX) has a current Cyclically Adjusted Book per Share of $6,631.77. The current Cyclically Adjusted Book per Share is $6,631.77. Tenax Therapeutics' overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Tenax Therapeutics (TENX), the current Cyclically Adjusted Book per Share is $6,631.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tenax Therapeutics Business Description

Other Exchanges YBO0:Germany
Address 101 Glen Lennox Drive, Suite 300, Chapel Hill, NC, USA, 27517
Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.
22GF Score

Get the complete analysis for TENX

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.49
Price